Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 18 executedNov 20, 2025 disclosed
DGX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
$14K reported value · 1.4% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
QUEST DIAGNOSTICS INC — Non-Qualifed Stock Option (right to buy)
Ticker
DGX
Shares
100
Price per share
$143.33
Value
$14,333
Execution date (reported)
Nov 18, 2025
Owned after transaction
7,484 shares
Rule 10b5-1 plan
Yes, as checked by the filer
Days from execution to publication
2
Calculation
Value = shares × reported price per share
Shares: 100
Price: $143.33
= $14,333
What this establishes
Delaney Mark E filed this Form 4 reporting a option exercise of DGX on Nov 18, 2025. It became public on Nov 20, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
SVP & Chief Commercial Officer
Delaney Mark Ecik:0001955265
Issuer
QUEST DIAGNOSTICS INCcik:0001022079
Revision history · 0
No field has changed since this record was first ingested.
